PROCEPT BioRobotics Corporation PRCT Accounts Receivable, Credit Loss Expense (Reversal)

Accounts Receivable, Credit Loss Expense (Reversal) at other companies

Envista Holdings CorporationNVST

——

iRadimedIRMD

——

MedtronicMDT

——

Other financials

Income statement

See full

Revenue$83.1M+20.2%

Gross profit$53.9M+22.2%

Operating income-$32.6M-18.8%

Net income-$31.6M-27.9%

EPS (diluted)-$0.56-24.4%

Balance sheet

See full

Cash & equivalents$12.2M-96.2%

Total debt$78.0M-11.8%

Total equity$347.7M-10.7%

Total assets$487.1M-6.2%

Cash flow

See full

Operating cash flow-$38.1M-125%

CapEx$2.9M+58.7%

Free cash flow-$41.0M-118%

Valuation

See full

Market cap$1.19B-24.8%

Enterprise value$1.25B—

P/S3.7×—

Profitability

See full

Gross margin64%+1.3pp

Operating margin-33.9%-3.8pp

Net margin-31.8%-3.4pp

FCF margin-25%-5.7pp

Returns & leverage

See full

Return on equity-27.8%+0.2pp

Debt / equity0.2×0.0×

Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's accounts receivable, credit loss expense (reversal).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's accounts receivable, credit loss expense (reversal)?: PROCEPT BioRobotics Corporation (PRCT) reported accounts receivable, credit loss expense (reversal) of $274K in Q1 2026.
How has PROCEPT BioRobotics Corporation's accounts receivable, credit loss expense (reversal) changed year-over-year?: PROCEPT BioRobotics Corporation's accounts receivable, credit loss expense (reversal) decreased by 17.0% year-over-year, from $330K to $274K.